Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed

Trial Identifier: 201436
Sponsor: GlaxoSmithKline
Collaborator:
No
NCTID:: NCT02339155
Start Date: February 2015
Primary Completion Date: January 2017

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
United States, Florida Edgewater, Florida, United States, 32132
United States, Kansas Overland Park, Kansas, United States, 66211
United States, Tennessee Knoxville, Tennessee, United States, 37920